Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 2035-2036

  Mor, Natan ^a,b   Esfandiari, Adeleh ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; PYRAZINAMIDE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL LYSATE; CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RADIOMETRY; TUBERCULOSIS;

EID: 0030853549     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.2035     Document Type: Article

References (19)

1. American Thoracic Society. 1986. Treatment of tuberculosis and tuberculosis infection in adults and children: official statement. Am. Rev. Respir. Dis. 134:355-363.
2. Bass, J. B., Jr., L. S. Farer, P. C. Hopewell, R. O'Brien, R. F. Jacobs, F. Ruben, D. E. Snider, Jr., and G. Thornton. 1994. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149:1359-1374.
3. Biehle, J., and S. J. Cavalieri. 1992. In vitro susceptibility of Mycobacterium kansasii to clarithromycin. Antimicrob. Agents Chemother. 36:2039-2041.
4. Brown, B. A., R. J. Wallace, Jr., G. O. Onyi, V. De Rosas, and R. J. Wallace III. 1992. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob. Agents Chemother. 36:180-184.
5. Cavalieri, S. J., J. R. Biehle, and W. E. Sanders, Jr. 1995. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39: 1542-1545.
6. Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. Morbid. Mortal. Weekly Rep. 38(Suppl.):1-25.
7. Crowle, A. J., J. A. Sbarbaro, and M. H. May. 1986. Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages. Am. Rev. Respir. Dis. 134:1052-1055.
8. Crowle, A. J. 1988. The tubercle bacillus-human macrophage relationship studies in vitro, p. 99-135. In M. Bendinellis, and H. Friedman (ed.), Mycobacterium tuberculosis. Interactions with the immune system. Plenum Publishing Corp., New York, N.Y.
9. Davidson, P. T., and H. Q. Le. 1992. Drug treatment of tuberculosis. Drugs 43:651-673.
10. Ferebee, S. H. 1970. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv. Tuberc. Res. 17:28-106.
11. Fernandes, P. B., D. J. Hardy, D. McDaniel, C. W. Hanson, and R. N. Swanson. 1989. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob. Agents Chemother. 33:1531-1534.
12. Gorzynski, E. A., S. I. Gutman, and W. Allen. 1989. Comparative antimycobacterial activities of difloxacin, temofloxacin, enoxacin, perfloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. Antimicrob. Agents Chemother. 33:591-592.
13. Hardy, D. J., D. R. P. Guay, and R. N. Jones. 1992. Clarithromycin, a unique macrolide: a pharmacokinetic, microbiological and clinical overview. Diagn. Microbiol. Infect. Dis. 15:39-53.
14. Ji, B., E. G. Perani, and J. H. Grosset. 1991. Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. Antimicrob. Agents Chemother. 35:579-581.
15. Konno, K., F. M. Feldmann, and W. McDermott. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95:461-469.
16. Salfinger, M., A. J. Crowle, and L. B. Reller. 1990. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in culture human macrophages and in the BACTEC system. J. Infect. Dis. 182:201-207.
17. Sbarbaro, J. A., M. D. Iseman, and A. J. Crowle. 1992. Synergism of rifampin and pyrazinamide within human macrophage. Am. Rev. Respir. Dis. 146: 1448-1451.
18. Sbarbaro, J. A., M. D. Iseman, and A. J. Crowle. 1996. Combined effect of pyrazinamide and ofloxacin within human macrophage. Tubercle Lung Dis. 77:491-495.
19. Truffort-Pernot, C., N. Lounis, J. H. Grosset, and B. Ji. 1995. Clarithromycin is inactive against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:2827-2828.